Exchange: NSE·Updated 04:00 PM GMT+5:30
News
all
press releases
Who is Claire Mazumdar? Meet Kiran Mazumdar-Shaw’s chosen successor at Biocon
Biocon Founder and Executive Chairperson Kiran Mazumdar-Shaw has chosen her niece Claire Mazumdar to succeed her as the biotech entrepreneur laid out a succession plan for India’s leading biotech firm. Mazumdar-Shaw (73), who has no children, in a post on X, confirmed reports about the succession planning in Biocon and that she has choosen niece […]
cityfalcon.com
More News
Mazumdar-Shaw picks niece Claire as Biocon successor
India Business News: Kiran Mazumdar-Shaw, founder and chairperson of Biocon, has found her successor within the family. She outlined a gradual succession plan, naming her .
cityfalcon.com
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garage
Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who built the company from a garage into a global biotech leader, Kiran is ensuring continuity by handing over to a science-driven leader while remaining at the helm during the transition.
cityfalcon.com
Biocon Founder Kiran Mazumdar-Shaw Proposes Niece As Successor Of India’s Biopharma Major
Biocon founder and chairperson Kiran Mazumdar-Shaw has proposed her niece as her successor. In a formal succession plan for the company, the 73-year-old matriarch has put forward the name of Claire Mazumdar, currently the chief executive officer of Bicara Therapeutics
cityfalcon.com
Why Sun Pharma’s massive Organon buyout is winning over investors where Lupin, Biocon failed
Sun Pharma’s acquisition of Organon marks a pivot toward biosimilars, utilizing a cheap valuation and strong cash reserves to avoid the chronic post-merger stock slumps seen by Indian rivals.
cityfalcon.com
Sensex, Nifty Poised For A Cautious Opening; Reliance, Infosys, Fortis, Wipro, Biocon, Vikram Solar, LTIMindtree Stocks Are In Focus
Indian conglomerate Reliance Industries is expected to post its Q2 earnings today.
Stocktwits
Will Trump’s 100% Tariffs Derail Indian Pharma Stocks? SEBI Analyst Flags Key Levels For Traders
The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.
Stocktwits
India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s
The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.
Stocktwits
Top Breakout Stock Ideas: Analysts Pick Biocon, KFin Tech, Poly Medicure, Sammaan Capital And More
Stocks such as Elgi Equipment, Supriya Life and Bajaj Consumer are on the breakout radar with upside potential, say analysts.
Stocktwits
Trading Radar For September 18: Biocon, Indosolar, Yes Bank, Cochin Shipyard, Dixon, Hyundai Stocks Are On Investors’ Watchlist
The broader markets are expected to open on a positive note after the US Federal Reserve slashed the benchmark interest rate by 25 basis points.
Stocktwits

Advertisement|Remove ads.